Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
基本信息
- 批准号:7658224
- 负责人:
- 金额:$ 33.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-15 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AnabolismApoptosisApoptoticArrestinsBiological PreservationBone Mineral ContentsBone remodelingCell CommunicationCell NucleusCell membraneCellsClathrinCommunicationComplexConnexin 43ConnexinsCyclic AMPDefectDinoprostoneDiseaseEmbryoEnvironmentExtracellular Signal Regulated KinasesFailureFractureFunctional disorderG-Protein-Coupled ReceptorsGap JunctionsGene ExpressionGene Expression RegulationGlucocorticoidsHormonalHormonesIn VitroInhibition of ApoptosisKnockout MiceMaintenanceMechanical StimulationMechanicsMediatingMembrane ProteinsMitogen-Activated Protein KinasesMusNuclearOsteoblastsOsteoclastsOsteocytesOsteogenesisParathyroid HormonesPathway interactionsPhosphotransferasesPreventionProductionPropertyProtein FamilyRoleScaffolding ProteinSignal PathwaySignal TransductionSkeletonStimulusTestingThickTimeTissuesWild Type MouseWorkanalogbasebisphosphonatebonebone cellbone strengthextracellulargap junction channelhuman PTH proteinimprovedin vivonovelpreventpublic health relevanceresponsescaffoldtool
项目摘要
DESCRIPTION (provided by applicant): Connexins (Cx) are a family of proteins essential for cell-to-cell communication and for the communication of cells with their environment. Cx43 is the most abundant connexin expressed in bone cells. The importance of Cx43 expression in the skeleton has been established by the demonstration of the osteoblast dysfunction and delay ossification in embryos of Cx43 null mice. However, the role of Cx43 and, in particular Cx43 hemichannels expressed in unopposed cell membranes, is far from being completely understood. In studies leading to this application it was demonstrated that bisphosphonates, besides stopping osteoclast-mediated resorption, might preserve bone strength at least in part by promoting osteoblast and osteocyte viability and that Cx43 expression is required for this survival effect. Thus, inhibition of apoptosis by bisphosphonates requires opening of Cx43 hemichannels, activation of the extracellular signal-regulated kinases (ERKs) and extra-nuclear retention of the kinases due to their interaction with the scaffolding protein (-arrestin. Cx43 is also required for prevention of osteoblast apoptosis by parathyroid hormone (PTH) in vitro; and the anabolic response to intermittent administration of the hormone is blunted in mice deficient mice in Cx43. In addition, Cx43 might be also involved in mechanotransduction in the skeleton. Thus, mechanical stimulation increases Cx43 expression, gap junction communication and hemichannel opening in osteoblasts and osteocytes. Based on this evidence, it is hypothesized that Cx43 is a crucial component of signaling pathways activated by pharmacologic, hormonal and mechanical stimuli in osteoblasts and osteocytes, via its involvement in hemichannels or gap junctions or its scaffolding properties. This hypothesis will be tested by a combination of in vitro and in vivo approaches. Studies in Aim 1 will examine the in vivo relevance of the Cx43/(-arrestin/ERK pathway for bisphosphonate actions on bone using bisphosphonate analogs that selectively activate this pathway; and they will delineate the mechanism by which association of Cx43, ERKs and (-arrestin leads to retention of ERKs outside the nucleus and the internalization of Cx43. Studies in Aim 2 will determine the role of Cx43 in the anti-apoptotic effect of PTH in vivo by examining whether the lack of anabolic effect of intermittent PTH administration to mice deficient in Cx43 is due to the inability of PTH to prevent osteoblast apoptosis. Aim 3 will define the role of Cx43 hemichannels in mechanotransduction in vivo and in vitro. This will be accomplished by investigating whether changes in gene expression and the anabolic response to mechanical loading are altered in Cx43 deficient mice; and whether Cx43 is required for the effects of mechanical stimulation in osteoblasts and osteocytes in vitro. We expect that this work will provide opportunities to improve the treatment of diseases with increased bone fragility. PUBLIC HEALTH RELEVANCE: These studies will advance our understanding of the role of Cx43 in the response of the skeleton to pharmacotherapeutic, hormonal and mechanical stimuli. We expect that this work will provide opportunities to improve the treatment of diseases with increased bone fragility.
描述(申请人提供):连接蛋白(Cx)是一个蛋白质家族,对细胞间的交流和细胞与环境的交流都是必不可少的。Cx43是骨细胞中表达最丰富的连接蛋白。Cx43基因缺失小鼠胚胎中成骨细胞功能障碍和延迟成骨的研究证实了Cx43在骨骼中表达的重要性。然而,Cx43的作用,特别是表达在非对位细胞膜上的Cx43半通道,还远未完全被了解。在导致这一应用的研究中,已经证明双膦酸盐除了阻止破骨细胞介导的吸收外,可能至少部分地通过促进成骨细胞和骨细胞的活性来保持骨强度,并且Cx43的表达是这种生存效应所必需的。因此,双膦酸盐抑制细胞凋亡需要开放Cx43半通道,激活细胞外信号调节蛋白(ERKs),并由于它们与支架蛋白(-arrestin)的相互作用而将其保留在核外。Cx43也是甲状旁腺激素(PTH)在体外防止成骨细胞凋亡所必需的;在Cx43基因缺陷的小鼠中,间歇给予激素的合成代谢反应被钝化。此外,Cx43还可能参与骨骼的机械转导。因此,机械刺激增加了成骨细胞和骨细胞中Cx43的表达、缝隙连接通讯和半通道开放。根据这一证据,推测Cx43是成骨细胞和骨细胞中由药物、激素和机械刺激激活的信号通路的重要组成部分,它通过参与半月板或缝隙连接或其支架特性而激活。这一假设将通过体外和体内相结合的方法进行验证。目标1的研究将使用选择性激活双膦酸类化合物的双膦酸类化合物来研究Cx43/(-arrestin/ERK)途径与双膦酸骨作用的体内相关性;他们将描绘Cx43、ERKs和(-arrestin)的结合导致ERKs滞留在核外和Cx43内化的机制。Aim 2的研究将通过检测间歇给予Cx43缺陷小鼠的合成代谢作用是否由于PTH不能阻止成骨细胞凋亡来确定Cx43在体内PTH抗凋亡作用中的作用。目的3将确定Cx43半通道在体内和体外的机械转导中的作用。这将通过研究Cx43缺陷小鼠的基因表达变化和对机械负荷的合成代谢反应是否发生改变,以及Cx43是否在体外成骨细胞和骨细胞的机械刺激效果中所必需的来完成。我们期待这项工作将为改善骨脆性增加的疾病的治疗提供机会。公共卫生相关性:这些研究将促进我们对Cx43在骨骼对药物治疗、激素和机械刺激的反应中的作用的理解。我们期待这项工作将为改善骨脆性增加的疾病的治疗提供机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lilian Irene Plotkin其他文献
Lilian Irene Plotkin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lilian Irene Plotkin', 18)}}的其他基金
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
- 批准号:
10508931 - 财政年份:2022
- 资助金额:
$ 33.22万 - 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的影响
- 批准号:
10666647 - 财政年份:2022
- 资助金额:
$ 33.22万 - 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
- 批准号:
10711910 - 财政年份:2022
- 资助金额:
$ 33.22万 - 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
- 批准号:
10408018 - 财政年份:2021
- 资助金额:
$ 33.22万 - 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
- 批准号:
10259555 - 财政年份:2021
- 资助金额:
$ 33.22万 - 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
- 批准号:
10618952 - 财政年份:2021
- 资助金额:
$ 33.22万 - 项目类别:
Osteocyte Apoptosis and Regulation of Bone Resorption with Aging
骨细胞凋亡和骨吸收随衰老的调节
- 批准号:
9212771 - 财政年份:2015
- 资助金额:
$ 33.22万 - 项目类别:
Osteocyte apoptosis and regulation of bone resorption with aging
衰老过程中骨细胞凋亡和骨吸收的调节
- 批准号:
9308117 - 财政年份:2015
- 资助金额:
$ 33.22万 - 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
- 批准号:
8049744 - 财政年份:2008
- 资助金额:
$ 33.22万 - 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
- 批准号:
8241176 - 财政年份:2008
- 资助金额:
$ 33.22万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 33.22万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 33.22万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 33.22万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 33.22万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 33.22万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 33.22万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 33.22万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 33.22万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 33.22万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 33.22万 - 项目类别:














{{item.name}}会员




